NOC for Medical Science Liaison or Medical Advisor

[Obai]

Hello everyone.
I am wondering what is the NOC for Medical science liaison or Medical advisor.
Thanks in advance.

 

[Obai]

Nobody knows?

 

[ishq74]

Nobody knows?

You need to write your duties here to get any help, title does not matter, duties matter.

 

[Obai]

You need to write your duties here to get any help, title does not matter, duties matter.

Thanks for the clarification.

The Medical Science Liaison (MSL) is a healthcare consulting professional representing the pharmaceutical company as an extension into the medical healthcare community

Medical Science Liaison will be accountable for bridging the education, information and awareness gap between the industry and the medical community by functioning as the intermediary between the pharmaceutical company and the physician, serving roles in both the transmission of beneficial compound information and the gathering of in-field medical intelligence.


KEY RESPONSIBILITIES:


Interaction with physicians and Key Opinion Leaders (KOL):


Disease management:

• Provide KOls with the necessary information and educational materials to discuss and safely prescribe medication to their patients and to ensure standardization of messaging transmitted within the medical community. The educational material may include, but is not limited to, clinical trial results, safety and efficacy data, educational updates specific to a therapeutic area, continuing medical education, and speaking opportunities.
• The educational perspective allows for the development of important networks with KOLs and decision makers to ensure a healthy product lifecycle.
• Conduct events such as advisory board meetings, speaker training, workshops and conferences.
• Share with the KOLs products’ information including scientific articles and recent guidelines.
• On reactive basis, responding to KOL queries about the off label use of the pharmaceutical company products.
• Obtain feedback that provides insight for physician initiated trials, clinical trial possibilities, educational platform development, safety, and compliance.

Disease awareness:

• Increase disease state awareness among KOLs in discussing the latest therapies and provide assistance in building knowledge specific to targeted disease pathways.
• Identify new and innovative medical findings in different regions which may result in the development of publications and providing unique data and insight to these respective regions.

Development:

• Through regular accessibility to diverse medical journals, encourages KOLs being updated to the recent publications and international guidelines and Update KOLs on press releases (New studies and partnerships).
• Support the pharmaceutical company' speakers at scientific meetings through speaker briefings and preparing slides and presentations .
• Answer KOL queries through Q&As and Bibliographic searches

Ensuring Patients’ safety & compliance:

• Effectively communicate and distribute relevant educational materials, which enhance awareness within the healthcare community and prioritize the benefit for patients and aid in the enhancement of the practice of medicine. Emphasis is placed on existing data which supports the importance of establishing and maintaining national patient safety goals
• Ensure compliance to local & global pharmacovigilance reporting procedures & timelines

 

[ishq74]

Thanks for the clarification.

The Medical Science Liaison (MSL) is a healthcare consulting professional representing the pharmaceutical company as an extension into the medical healthcare community

Medical Science Liaison will be accountable for bridging the education, information and awareness gap between the industry and the medical community by functioning as the intermediary between the pharmaceutical company and the physician, serving roles in both the transmission of beneficial compound information and the gathering of in-field medical intelligence.


KEY RESPONSIBILITIES:


Interaction with physicians and Key Opinion Leaders (KOL):


Disease management:

• Provide KOls with the necessary information and educational materials to discuss and safely prescribe medication to their patients and to ensure standardization of messaging transmitted within the medical community. The educational material may include, but is not limited to, clinical trial results, safety and efficacy data, educational updates specific to a therapeutic area, continuing medical education, and speaking opportunities.
• The educational perspective allows for the development of important networks with KOLs and decision makers to ensure a healthy product lifecycle.
• Conduct events such as advisory board meetings, speaker training, workshops and conferences.
• Share with the KOLs products’ information including scientific articles and recent guidelines.
• On reactive basis, responding to KOL queries about the off label use of the pharmaceutical company products.
• Obtain feedback that provides insight for physician initiated trials, clinical trial possibilities, educational platform development, safety, and compliance.

Disease awareness:

• Increase disease state awareness among KOLs in discussing the latest therapies and provide assistance in building knowledge specific to targeted disease pathways.
• Identify new and innovative medical findings in different regions which may result in the development of publications and providing unique data and insight to these respective regions.

Development:

• Through regular accessibility to diverse medical journals, encourages KOLs being updated to the recent publications and international guidelines and Update KOLs on press releases (New studies and partnerships).
• Support the pharmaceutical company' speakers at scientific meetings through speaker briefings and preparing slides and presentations .
• Answer KOL queries through Q&As and Bibliographic searches

Ensuring Patients’ safety & compliance:

• Effectively communicate and distribute relevant educational materials, which enhance awareness within the healthcare community and prioritize the benefit for patients and aid in the enhancement of the practice of medicine. Emphasis is placed on existing data which supports the importance of establishing and maintaining national patient safety goals
• Ensure compliance to local & global pharmacovigilance reporting procedures & timelines

Noc 4165 Health Policy Researchers, Consultans and Program Officers.

 

[Obai]

Thanks for the clarification.

The Medical Science Liaison (MSL) is a healthcare consulting professional representing the pharmaceutical company as an extension into the medical healthcare community

Medical Science Liaison will be accountable for bridging the education, information and awareness gap between the industry and the medical community by functioning as the intermediary between the pharmaceutical company and the physician, serving roles in both the transmission of beneficial compound information and the gathering of in-field medical intelligence.


KEY RESPONSIBILITIES:


Interaction with physicians and Key Opinion Leaders (KOL):


Disease management:

• Provide KOls with the necessary information and educational materials to discuss and safely prescribe medication to their patients and to ensure standardization of messaging transmitted within the medical community. The educational material may include, but is not limited to, clinical trial results, safety and efficacy data, educational updates specific to a therapeutic area, continuing medical education, and speaking opportunities.
• The educational perspective allows for the development of important networks with KOLs and decision makers to ensure a healthy product lifecycle.
• Conduct events such as advisory board meetings, speaker training, workshops and conferences.
• Share with the KOLs products’ information including scientific articles and recent guidelines.
• On reactive basis, responding to KOL queries about the off label use of the pharmaceutical company products.
• Obtain feedback that provides insight for physician initiated trials, clinical trial possibilities, educational platform development, safety, and compliance.

Disease awareness:

• Increase disease state awareness among KOLs in discussing the latest therapies and provide assistance in building knowledge specific to targeted disease pathways.
• Identify new and innovative medical findings in different regions which may result in the development of publications and providing unique data and insight to these respective regions.

Development:

• Through regular accessibility to diverse medical journals, encourages KOLs being updated to the recent publications and international guidelines and Update KOLs on press releases (New studies and partnerships).
• Support the pharmaceutical company' speakers at scientific meetings through speaker briefings and preparing slides and presentations .
• Answer KOL queries through Q&As and Bibliographic searches

Ensuring Patients’ safety & compliance:

• Effectively communicate and distribute relevant educational materials, which enhance awareness within the healthcare community and prioritize the benefit for patients and aid in the enhancement of the practice of medicine. Emphasis is placed on existing data which supports the importance of establishing and maintaining national patient safety goals
• Ensure compliance to local & global pharmacovigilance reporting procedures & timelines

Noc 4165 Health Policy Researchers, Consultans and Program Officers.

Thank you very much! really appreciate it

 

[Obai]

Noc 4165 Health Policy Researchers, Consultans and Program Officers.

Thank you very much! really appreciate it

 

[Gracejerrin]

i am also working as a medical affairs assosciate similar job duties like that of an medical science liasion of medical advisor support
are u sure about this noc 4165 fits

 

[K.medicalaffairs]

has this NOC 4165 works?

 

[drraj]

Thanks for the clarification.

The Medical Science Liaison (MSL) is a healthcare consulting professional representing the pharmaceutical company as an extension into the medical healthcare community

Medical Science Liaison will be accountable for bridging the education, information and awareness gap between the industry and the medical community by functioning as the intermediary between the pharmaceutical company and the physician, serving roles in both the transmission of beneficial compound information and the gathering of in-field medical intelligence.


KEY RESPONSIBILITIES:


Interaction with physicians and Key Opinion Leaders (KOL):


Disease management:

• Provide KOls with the necessary information and educational materials to discuss and safely prescribe medication to their patients and to ensure standardization of messaging transmitted within the medical community. The educational material may include, but is not limited to, clinical trial results, safety and efficacy data, educational updates specific to a therapeutic area, continuing medical education, and speaking opportunities.
• The educational perspective allows for the development of important networks with KOLs and decision makers to ensure a healthy product lifecycle.
• Conduct events such as advisory board meetings, speaker training, workshops and conferences.
• Share with the KOLs products’ information including scientific articles and recent guidelines.
• On reactive basis, responding to KOL queries about the off label use of the pharmaceutical company products.
• Obtain feedback that provides insight for physician initiated trials, clinical trial possibilities, educational platform development, safety, and compliance.

Disease awareness:

• Increase disease state awareness among KOLs in discussing the latest therapies and provide assistance in building knowledge specific to targeted disease pathways.
• Identify new and innovative medical findings in different regions which may result in the development of publications and providing unique data and insight to these respective regions.

Development:

• Through regular accessibility to diverse medical journals, encourages KOLs being updated to the recent publications and international guidelines and Update KOLs on press releases (New studies and partnerships).
• Support the pharmaceutical company' speakers at scientific meetings through speaker briefings and preparing slides and presentations .
• Answer KOL queries through Q&As and Bibliographic searches

Ensuring Patients’ safety & compliance:

• Effectively communicate and distribute relevant educational materials, which enhance awareness within the healthcare community and prioritize the benefit for patients and aid in the enhancement of the practice of medicine. Emphasis is placed on existing data which supports the importance of establishing and maintaining national patient safety goals
• Ensure compliance to local & global pharmacovigilance reporting procedures & timelines

Hi, did you find correct NOC for MSL role?